Dynavax Technologies Corporation Company Name:
DVAX Stock Symbol:
NASDAQ Market:
Dynavax Technologies Corporation Website:
News, Short Squeeze, Breakout and More Instantly...
Dynavax Appoints Kelly MacDonald as Chief Financial Officer PR Newswire EMERYVILLE, Calif. , Jan. 20, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today a...
Shares of Dynavax Technologies (NASDAQ: DVAX) were vaulting 7.2% higher as of 11:44 a.m. EST on Thursday. The big jump came after the biotech announced results from an ongoing clinical study evaluating hepatitis B vaccine Heplisav-B in patients undergoing hemodialysis. As you mi...
Dynavax Announces Final Immunogenicity and Interim Safety Results from Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing Hemodialysis - Demonstrated seroprotection rate of 89.3% at week 20 after 4 standard doses of HEPLISAV-B - HEPLISAV-B is well tolerated; no safe...